ID
13166
Description
A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00510133
Link
https://clinicaltrials.gov/show/NCT00510133
Keywords
Versions (1)
- 1/21/16 1/21/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 21, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myelogenous Leukemia NCT00510133
Eligibility Acute Myelogenous Leukemia NCT00510133
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
complete remission and good risk cytogenic features
Data type
boolean
Alias
- UMLS CUI [1]
- C0677874
Description
cns leukemia or leptomeningeal disease
Data type
boolean
Alias
- UMLS CUI [1]
- C1332884
Description
stem cell transplant
Data type
boolean
Alias
- UMLS CUI [1]
- C1504389
Description
allergy to beta-lactams
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0282215
Description
autoimmune disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0004364
Description
clinically significant pulmonary or cardiovascular disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Similar models
Eligibility Acute Myelogenous Leukemia NCT00510133
- StudyEvent: Eligibility
C0232804 (UMLS CUI [2])
C0282215 (UMLS CUI [1,2])